EDGAR Filing Documents for 0001047469-13-002788

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-13-002788

Filing Date

2013-03-15

Accepted

2013-03-15 08:05:07

Documents

Period of Report

2012-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a2213414z10-k.htm	10-K	1094958
2	EX-23.1.1	a2213414zex-23_11.htm	EX-23.1.1	2969
3	EX-31.1.1	a2213414zex-31_11.htm	EX-31.1.1	8196
4	EX-31.2.1	a2213414zex-31_21.htm	EX-31.2.1	8207
5	EX-32.1.1	a2213414zex-32_11.htm	EX-32.1.1	5432
12	G495007.JPG	g495007.jpg	GRAPHIC	88960
	Complete submission text file	0001047469-13-002788.txt		8568359

Data Files

Seq	Description	Document	Type	Size
6	EX-101.INS	osir-20121231.xml	EX-101.INS	1223120
7	EX-101.SCH	osir-20121231.xsd	EX-101.SCH	63529
8	EX-101.CAL	osir-20121231_cal.xml	EX-101.CAL	78514
9	EX-101.DEF	osir-20121231_def.xml	EX-101.DEF	257248
10	EX-101.LAB	osir-20121231_lab.xml	EX-101.LAB	1065544
11	EX-101.PRE	osir-20121231_pre.xml	EX-101.PRE	519453

Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046

Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819

OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)